Cargando…

Linagliptin Limits High Glucose Induced Conversion of Latent to Active TGFß through Interaction with CIM6PR and Limits Renal Tubulointerstitial Fibronectin

BACKGROUND: In addition to lowering blood glucose in patients with type 2 diabetes mellitus, dipeptidyl peptidase 4 (DPP4) inhibitors have been shown to be antifibrotic. We have previously shown that cation independent mannose-6-phosphate receptor (CIM6PR) facilitates the conversion of latent to act...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gangadharan Komala, Muralikrishna, Gross, Simon, Zaky, Amgad, Pollock, Carol, Panchapakesan, Usha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624988/ https://www.ncbi.nlm.nih.gov/pubmed/26509887 http://dx.doi.org/10.1371/journal.pone.0141143

Ejemplares similares

Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells—Renoprotection in Diabetic Nephropathy?
por: Panchapakesan, Usha, et al.
Publicado: (2013)

Inhibition of Kidney Proximal Tubular Glucose Reabsorption Does Not Prevent against Diabetic Nephropathy in Type 1 Diabetic eNOS Knockout Mice
por: Gangadharan Komala, Muralikrishna, et al.
Publicado: (2014)

The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Preserves Endothelial Function in Mesenteric Arteries from Type 1 Diabetic Rats without Decreasing Plasma Glucose
por: Salheen, Salheen M., et al.
Publicado: (2015)

CIM : consideraciones básicas
por: Baumgartner, Horst
Publicado: (1991)

Combination of modified carbapenem inactivation method (mCIM) and EDTA-CIM (eCIM) for phenotypic detection of carbapenemase-producing Enterobacteriaceae
por: Tsai, Ya-Min, et al.
Publicado: (2020)

Integration of robots into CIM /
Publicado: (1992)

Semicarbazide-sensitive amine oxidase inhibition ameliorates albuminuria and glomerulosclerosis but does not improve tubulointerstitial fibrosis in diabetic nephropathy
por: Wong, May YW, et al.
Publicado: (2020)

GDF5 Regulates TGFß-Dependent Angiogenesis in Breast Carcinoma MCF-7 Cells: In Vitro and In Vivo Control by Anti-TGFß Peptides
por: Margheri, Francesca, et al.
Publicado: (2012)

Investigating the Regulatory Process, Safety, Efficacy and Product Transparency for Nutraceuticals in the USA, Europe and Australia
por: Komala, Muralikrishna Gangadharan, et al.
Publicado: (2023)

The common information model CIM: IEC 61968/61970 and 62325 : a practical introduction to the CIM
por: Uslar, Mathias, et al.
Publicado: (2012)

Patients with idiopathic recurrent miscarriage have abnormally high TGFß+ blood NK, NKT and T cells in the presence of abnormally low TGFß plasma levels
por: Zhu, Li, et al.
Publicado: (2019)

LRG1 promotes angiogenesis by modulating endothelial TGFß signalling
por: Wang, Xiaomeng, et al.
Publicado: (2013)

Fabricación integrada por ordenador (CIM) /
por: Arnedo Rosel, José Ma
Publicado: (1992)

Novel complement factor H gene mutation causing atypical haemolytic uraemic syndrome: early Eculizumab prevents acute dialysis
por: Collett, James, et al.
Publicado: (2017)

A Variant Carbapenem Inactivation Method (CIM) for Acinetobacter baumannii Group with Shortened Time-to-Result: rCIM-A
por: Mitteregger, Dieter, et al.
Publicado: (2022)

"Stella" project: communications interface module (CIM)
por: Olofsson, Knut Soren, et al.
Publicado: (1980)

CIM-Based Smart Pose Detection Sensors
por: Chou, Jyun-Jhe, et al.
Publicado: (2022)

A Dynein Motor Attachment Complex Regulates TGFß/Smad3 Signaling
por: Jin, Qunyan, et al.
Publicado: (2013)

Generation of Rat Embryonic Germ Cells via Inhibition of TGFß and MEK Pathways
por: Mohammadi, Alireza, et al.
Publicado: (2015)

The Role of Dipeptidyl Peptidase – 4 Inhibitors in Diabetic Kidney Disease
por: Panchapakesan, Usha, et al.
Publicado: (2015)

Characterization of the mass-dependent transmission efficiency of a CIMS
por: Heinritzi, Martin, et al.
Publicado: (2016)

Faculty Feedback Program Evaluation in CIMS Multan, Pakistan
por: Shabbir, Ambreen, et al.
Publicado: (2020)

SRAM-Based CIM Architecture Design for Event Detection †
por: Sulaiman, Muhammad Bintang Gemintang, et al.
Publicado: (2022)

The Effect of Nutritional Status in the Pathogenesis of Critical Illness Myopathy (CIM)
por: Ogilvie, Hannah, et al.
Publicado: (2014)

The explainability of the latent variables is limited to the synthesis of electrocardiogram
por: Higaki, Akinori, et al.
Publicado: (2022)

T Cell-Specific Overexpression of TGFß1 Fails to Influence Atherosclerosis in ApoE-Deficient Mice
por: Reifenberg, Kurt, et al.
Publicado: (2013)

The Effects of Post-Mating Administration of Anti-IL-10 and Anti-TGFß on Conception Rates in Mice
por: Risvanli, Ali, et al.
Publicado: (2015)

GHZ States as Tripartite PR Boxes: Classical Limit and Retrocausality
por: Rohrlich, Daniel, et al.
Publicado: (2018)

Nanomedicines in the treatment of anemia in renal disease: focus on CERA (Continuous Erythropoietin Receptor Activator)
por: Panchapakesan, Usha, et al.
Publicado: (2007)

Models of Latent Tuberculosis: Their Salient Features, Limitations, and Development
por: Patel, Kamlesh, et al.
Publicado: (2011)

Latent Factors Limiting the Performance of sEMG-Interfaces
por: Lobov, Sergey, et al.
Publicado: (2018)

Amniotic Membrane Modifies the Genetic Program Induced by TGFß, Stimulating Keratinocyte Proliferation and Migration in Chronic Wounds
por: Alcaraz, Antonia, et al.
Publicado: (2015)

AP-1 and TGFß cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinoma
por: Yao, Catherine D., et al.
Publicado: (2020)

The clinical application of linagliptin in Asians
por: Cao, Chu-qing, et al.
Publicado: (2015)

Linagliptin: from bench to bedside
por: Doupis, John
Publicado: (2014)

Could disparities in PrEP uptake limit the public health benefit?
por: Keen, Phillip, et al.
Publicado: (2020)

Prevalence and Factors Associated with Sarcopenia in Patients on Maintenance Dialysis in Australia—A Single Centre, Cross-Sectional Study
por: Umakanthan, Marille, et al.
Publicado: (2021)

Comment on Mitteregger et al. A Variant Carbapenem Inactivation Method (CIM) for Acinetobacter baumannii Group with Shortened Time-to-Result: rCIM-A. Pathogens 2022, 11, 482
por: Muntean, Andrei-Alexandru, et al.
Publicado: (2022)

Fibronectin extra domain a limits liver dysfunction and protects mice during acute inflammation()
por: Venu, Vivek Krishna Pulakazhi, et al.
Publicado: (2023)

Psychometric Validation of the Growth Hormone Deficiency-Child Impact Measure (GHD-CIM)
por: Brod, Meryl, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_agknt1rja1iir49cqhh7su9d41